EA200801411A1 - Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях - Google Patents

Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях

Info

Publication number
EA200801411A1
EA200801411A1 EA200801411A EA200801411A EA200801411A1 EA 200801411 A1 EA200801411 A1 EA 200801411A1 EA 200801411 A EA200801411 A EA 200801411A EA 200801411 A EA200801411 A EA 200801411A EA 200801411 A1 EA200801411 A1 EA 200801411A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
bis
acyloxypropylcystein
conjugates
derivatives
Prior art date
Application number
EA200801411A
Other languages
English (en)
Inventor
Томас Эбенсен
Михель Морр
Карлос А. Гузман
Original Assignee
Хельмхольтц-Центрум Фюр Инфекционсфоршунг Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хельмхольтц-Центрум Фюр Инфекционсфоршунг Гмбх filed Critical Хельмхольтц-Центрум Фюр Инфекционсфоршунг Гмбх
Publication of EA200801411A1 publication Critical patent/EA200801411A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Настоящее изобретение относится к новым адъювантам и применениям в фармацевтических композициях, таких как вакцины. В частности, настоящее изобретение относится к новым конъюгатам типа бис-ацилоксицистеина, пригодным в качестве адъювантов и/или иммуномодуляторов для профилактической и/или терапевтической вакцинации при лечении инфекционных заболеваний, воспалительных заболеваний, аутоиммунных заболеваний, опухолей, аллергий, а также для контролирования фертильности в популяциях человека или животных. Соединения, в частности, пригодны не только в качестве системных, но предпочтительно в качестве мукозальных адъювантов. Кроме того, изобретение относится к их применениям в качестве активных ингредиентов в фармацевтических композициях.
EA200801411A 2005-11-22 2006-11-22 Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях EA200801411A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025431A EP1787660A1 (en) 2005-11-22 2005-11-22 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
PCT/EP2006/011182 WO2007059931A1 (en) 2005-11-22 2006-11-22 New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
EA200801411A1 true EA200801411A1 (ru) 2008-10-30

Family

ID=35787974

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801411A EA200801411A1 (ru) 2005-11-22 2006-11-22 Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях

Country Status (11)

Country Link
US (1) US8119689B2 (ru)
EP (2) EP1787660A1 (ru)
JP (1) JP5249041B2 (ru)
KR (1) KR20080069267A (ru)
CN (1) CN101360514A (ru)
AU (1) AU2006316791B2 (ru)
BR (1) BRPI0618847A2 (ru)
CA (1) CA2628736A1 (ru)
EA (1) EA200801411A1 (ru)
WO (1) WO2007059931A1 (ru)
ZA (1) ZA200804163B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2196196A1 (en) * 2008-12-10 2010-06-16 Medipol S.A. Compound, medicament, vaccine composition and nanocapsules
EP2305283A1 (en) 2009-09-24 2011-04-06 Helmholtz-Zentrum für Infektionsforschung GmbH Pharmaceutical compositions for treating dysregulated inflammatory diseases
WO2011138050A1 (en) 2010-05-07 2011-11-10 Helmholtz-Zentrum für Infektionsforschung GmbH Method for vaccination
CA2800424C (en) * 2010-06-04 2018-10-23 Inserm (Institut National De La Sante Et De La Recherche Medicale) B1,2 cyclic beta glucan compound for use to enhance adaptive immunity by activation of dendritic cells
CN103154251A (zh) * 2010-09-30 2013-06-12 佛兰瓦克斯有限责任公司 病毒体颗粒的生产
CA2938626A1 (en) 2013-07-26 2015-01-29 John Rothman Compositions to improve the therapeutic benefit of bisantrene
CN105126092A (zh) * 2015-09-30 2015-12-09 青岛农业大学 一种以壳寡糖为佐剂负载大肠杆菌菌毛黏附素的鸭疫里默氏菌菌影疫苗的制备方法及其应用
CA3094072A1 (en) * 2018-03-15 2019-09-19 Atossa Therapeutics, Inc. In situ methods of inducing of immune response
US20220388950A1 (en) * 2019-06-26 2022-12-08 Axelia Oncology Pty Ltd Novel molecules
CN112826928A (zh) * 2020-11-20 2021-05-25 郑州大学 一种cd40靶向树突状细胞纳米疫苗及其构建方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307958T3 (es) 2002-04-04 2008-12-01 Helmholtz-Zentrum Fur Infektionsforschung Gmbh Uso de un lipopeptido o una lipoproteina como adyuvante en la vacunacion terapeutica o profilactica.
EP1382352A1 (de) 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Bisacyloxypropylcystein-Konjugate und deren Verwendung
JP4412461B2 (ja) * 2002-11-20 2010-02-10 日油株式会社 修飾された生体関連物質、その製造方法および中間体
ES2562456T3 (es) * 2003-03-24 2016-03-04 Valneva Austria Gmbh Uso de un adyuvante que induce una respuesta inmune Th1 para mejorar las respuestas inmunes
DE10326303A1 (de) 2003-06-11 2004-12-30 Celares Gmbh Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung

Also Published As

Publication number Publication date
ZA200804163B (en) 2009-10-28
WO2007059931A1 (en) 2007-05-31
CA2628736A1 (en) 2007-05-31
AU2006316791A1 (en) 2007-05-31
KR20080069267A (ko) 2008-07-25
EP1973571A1 (en) 2008-10-01
CN101360514A (zh) 2009-02-04
JP2009517350A (ja) 2009-04-30
WO2007059931A8 (en) 2007-07-19
EP1787660A1 (en) 2007-05-23
AU2006316791B2 (en) 2012-07-12
US8119689B2 (en) 2012-02-21
BRPI0618847A2 (pt) 2011-10-04
JP5249041B2 (ja) 2013-07-31
US20090017106A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
WO2007054279A8 (en) Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
EA200801411A1 (ru) Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях
EA201290395A1 (ru) Иммуномодулирующие полипептиды, полученные из il-2, и их применение для лечения рака и хронических инфекций
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
MY157661A (en) Bendamustine pharmaceutical compositions
CY1117757T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
EA201500432A1 (ru) Соединения боронатного эфира и его фармацевтические составы
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
CY1116075T1 (el) Νεες συνθεσεις λιποσωματων
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
CY1119216T1 (el) Φαρμακευτικη συνθεση για εισπνοη
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
BRPI0907087A2 (pt) ácidos nucleicos de fórmula (i) (nuglxmgnnv)a e derivados dos mesmos como um agente imunoestimulante/adjuvante
EA201000424A1 (ru) Антитела к il-23
DE602007013618D1 (de) Antikörper gegen das humane cytomegalie-virus (hcmv)
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
CY1117237T1 (el) Συνθεσεις σταθερων τιακουμυκινων
CY1109843T1 (el) Αναλογα της βιταμινης d
EA200900900A1 (ru) Производные замещенных 3-фенил-1-(фенилтиенил)пропан-1-онов и 3-фенил-1-(фенилфуранил)пропан-1-онов, их получение и применение
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
BR112014011981A2 (pt) formulações farmacêuticas
MEP20908A (en) Thienopyrazoles
CY1114724T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων